Uso de estreptoquinasa recombinante intrapleural en una mujer embarazada con empiema pleural

Background: pneumonia complicates 0,78-2,7 per 1 000 pregnancies placing the mother and the fetus at risk. Empyema as a complication of pneumonia in a pregnant patient adds a high rate of morbidity and mortality to the mother and the fetus if one does not act quickly. Objective: to present the case of a pregnant woman of 33 weeks who developed a pleural empyema resulting from acquired pneumonia. Clinical case: 33-week gestated patient, asthmatic admitted to the intensive care unit of the University Hospital Manuel Ascunce Domenech with the diagnosis of severe pneumonia acquired in the community complicated with para-pneumonic effusion, which evolved into empyema. It was treated with a thoracotomy tube and fibrinolytic therapy, with good clinical and radiological evolution. Conclusions: Recombinant streptokinase can be used safely and effectively for the management of PE, as an intrapleural fibrinolytic agent, during pregnancy. DeCS: PREGNANCY COMPLICATIONS; STREPTOKINASE/therapeutic use; EMPYEMA, PLEURAL/DRUG THERAPY; EMPYEMA, PLEURAL/ complications; FIBRINOLYTIC AGENTS/therapeutic use.